Evidence map›Paper›PMID 39881908›Full record

ArticleCureus2024

Sarcoidosis-Like Reaction in a Patient With Psoriatic Arthritis Treated With Adalimumab.

João Oliveira, Martina Arandjelovic, Inês Pintor, Margarida Resendes, Flávio Pereira

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

João OliveiraInternal Medicine, Hospital Infante D. Pedro, Aveiro, PRT.
Martina ArandjelovicInfectious Diseases, Hospital Infante D. Pedro, Aveiro, PRT.
Inês PintorInternal Medicine, Hospital Infante D. Pedro, Aveiro, PRT.
Margarida ResendesInternal Medicine, Hospital Infante D. Pedro, Aveiro, PRT.
Flávio PereiraInternal Medicine, Hospital Infante D. Pedro, Aveiro, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A drug-induced sarcoidosis-like reaction (DISR) is a systemic granulomatous reaction indistinguishable from sarcoidosis and is associated with the administration of a medication. It typically exhibits a temporal relationship with the initiation of the drug (an average interval of 22 months) and tends to improve upon its discontinuation. Tumor necrosis factor (TNF) antagonists, including adalimumab, have been associated with the development of DISR. The case presented here describes a 33-year-old female patient with psoriatic arthritis treated with adalimumab, whose clinical presentation, imaging findings, and histology were consistent with DISR.

Indexed as

adalimumab (humira)anti-tnf agentsdrug-induced sarcoidosis-like reactionpsoriatic arthritis (psa)tumor necrosis factor

Identifiers

PMID39881908
PMCPMC11774629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.